Search
Novavax Inc
NVAXAdd to Watchlist
10.110USD
+0.110+1.10%
Close 09-18 16:00（ET）
1.66BMarket Cap
LossP/E TTM
After-hours 17:24 (ET)10.020USD-0.090-0.89%
After-hours 17:24 (ET)Novavax Inc (NVAX) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Novavax Inc in the past month.
Hold
2 Strong Buy
3 Buy
1 Hold
2 Sell
1 Strong Sell
Target Price
14.000USD+51.68%
NVAX Analyst Recommendation Trends
In the current month, NVAX has received 3 Buy Ratings, 1 Hold Ratings, and 2 Sell Ratings. NVAX average Analyst price target in the last month is 14.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
9
9
9
9
9
9
9
9
NVAX Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, NVAX EPS is projected to reach -0.232 in FY2026Q3, following reported EPS of -0.324 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.49
-0.23
-0.39
-0.23
-0.10
Actual
0.11
-0.06
-0.32
--
--
Surprise
+122.14%
+74.76%
+15.86%
--
--
FAQs
What is Novavax Inc's expected revenue for the next quarter?
Novavax Inc's expected revenue is 72.66M.
What is Novavax Inc's price target?
Analysts forecast that Novavax Inc's price target is USD 14.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 7.00.
How have Novavax IncNVAX's recent earnings per share performed?
The market expectation was USD -0.32, while Novavax IncNVAX's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for Novavax Inc?
Based on the ratings of Novavax Inc's stock from 9 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.